144 related articles for article (PubMed ID: 18073296)
21. Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.
Indhavivadhana S; Wongwananuruk T; Rattanachaiyanont M; Techatraisak K; Leerasiri P; Tanmahasamut P; Popijan M
J Med Assoc Thai; 2010 Jun; 93(6):653-60. PubMed ID: 20572369
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions.
Zabetian A; Hadaegh F; Azizi F
Diabetes Res Clin Pract; 2007 Aug; 77(2):251-7. PubMed ID: 17234299
[TBL] [Abstract][Full Text] [Related]
23. Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS).
Moebus S; Hanisch JU; Aidelsburger P; Bramlage P; Wasem J; Jöckel KH
Cardiovasc Diabetol; 2007 Sep; 6():22. PubMed ID: 17822558
[TBL] [Abstract][Full Text] [Related]
24. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
Nilsson PM; Engström G; Hedblad B
Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
[TBL] [Abstract][Full Text] [Related]
25. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
[TBL] [Abstract][Full Text] [Related]
26. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
[TBL] [Abstract][Full Text] [Related]
27. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome.
Benetos A; Thomas F; Pannier B; Bean K; Jégo B; Guize L
Am J Cardiol; 2008 Jul; 102(2):188-91. PubMed ID: 18602519
[TBL] [Abstract][Full Text] [Related]
28. Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese.
Cheung BM; Wat NM; Tam S; Thomas GN; Leung GM; Cheng CH; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Clin Endocrinol (Oxf); 2008 May; 68(5):730-7. PubMed ID: 17980012
[TBL] [Abstract][Full Text] [Related]
29. Prognostic interactions between cardiovascular risk factors.
Vishram JK
Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
[TBL] [Abstract][Full Text] [Related]
30. Association of the metabolic syndrome with vascular disease in an older Chinese population: Guangzhou Biobank Cohort Study.
Lao XQ; Thomas GN; Jiang CQ; Zhang WS; Yin P; Adab P; Lam TH; Cheng KK
J Endocrinol Invest; 2006 Dec; 29(11):989-96. PubMed ID: 17259796
[TBL] [Abstract][Full Text] [Related]
31. A comparison of two proposed definitions for metabolic syndrome in the Chinese adult population.
Yang W; Reynolds K; Gu D; Chen J; He J
Am J Med Sci; 2007 Sep; 334(3):184-9. PubMed ID: 17873532
[TBL] [Abstract][Full Text] [Related]
32. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5.
Gupta R; Sharma KK; Gupta A; Agrawal A; Mohan I; Gupta VP; Khedar RS; Guptha S
J Assoc Physicians India; 2012 Mar; 60():11-6. PubMed ID: 22799108
[TBL] [Abstract][Full Text] [Related]
33. Metabolic syndrome in the Philippine general population: prevalence and risk for atherosclerotic cardiovascular disease and diabetes mellitus.
Morales DD; Punzalan FE; Paz-Pacheco E; Sy RG; Duante CA;
Diab Vasc Dis Res; 2008 Mar; 5(1):36-43. PubMed ID: 18398811
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of metabolic syndrome at age 16 using the International Diabetes Federation paediatric definition.
Pirkola J; Tammelin T; Bloigu A; Pouta A; Laitinen J; Ruokonen A; Tapanainen P; Järvelin MR; Vääräsmäki M
Arch Dis Child; 2008 Nov; 93(11):945-51. PubMed ID: 18456683
[TBL] [Abstract][Full Text] [Related]
35. Influence of criteria used in determining prevalence of metabolic syndrome (NCEP-ATPIII versus IDF) in patients with intermittent claudication.
Zerati AE; Monteiro Guimarães AL; Miranda de Carvalho HA; Saes GF; Ragazzo L; Wolosker N; de Luccia N
Ann Vasc Surg; 2014 Apr; 28(3):640-3. PubMed ID: 24405772
[TBL] [Abstract][Full Text] [Related]
36. Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women.
Carlsson AC; Wändell PE; Halldin M; de Faire U; Hellénius ML
Metab Syndr Relat Disord; 2009 Jun; 7(3):231-41. PubMed ID: 19284315
[TBL] [Abstract][Full Text] [Related]
37. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
Misra KB; Endemann SW; Ayer M
Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of metabolic syndrome defined by the International Diabetes Federation and National Cholesterol Education Program criteria among Thai adults.
Aekplakorn W; Chongsuvivatwong V; Tatsanavivat P; Suriyawongpaisal P
Asia Pac J Public Health; 2011 Sep; 23(5):792-800. PubMed ID: 21984495
[TBL] [Abstract][Full Text] [Related]
39. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria.
Harzallah F; Alberti H; Ben Khalifa F
Diabet Med; 2006 Apr; 23(4):441-4. PubMed ID: 16620275
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: a report of a national survey.
Malik M; Razig SA
Metab Syndr Relat Disord; 2008 Sep; 6(3):177-86. PubMed ID: 18699721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
